RESULTS OF HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE TREATMENT OF MEDULLOBLASTOMA

被引：0
|
作者：
Gevorgian, A. [1 ]
Morozova, E. [1 ]
Kazantsev, I. [1 ]
Iukhta, T. [1 ]
Safonova, S. [1 ]
Punanov, Y. [1 ]
Afanasyev, B. [1 ]
Zheludkova, O. [2 ]
机构：
[1] Pavlov First St Petersburg State Med Univ, Gorbacheva Mem Inst Children Oncol Hematol & Tran, St Petersburg, Russia
[2] Russian Sci Ctr Roentgenoradiol, Neurooncol, Moscow, Russia
来源：
PEDIATRIC BLOOD & CANCER | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-142
引用
收藏
页码：S275 / S275
页数：1
相关论文
共 50 条
  • [41] High-dose chemotherapy and autologous stem cell transplantation as treatment for high-risk breast cancer
    Tallman, MS
    Gradishar, WJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (Suppl 1) : S60 - S67
  • [42] High-dose chemotherapy and autologous stem cell transplantation as treatment for high-risk breast cancer
    Martin S. Tallman
    William J. Gradishar
    Cancer Chemotherapy and Pharmacology, 1998, 42 : S60 - S67
  • [43] Results of high-dose chemotherapy (HDCT) with autologous hematopoietic stem cell transplantation (auto-HSCT) in the treatment of ewing sarcoma family tumors (ESFT)
    Iukhta, Tatiana
    Kazantsev, Ilya
    Gevorgian, Asmik
    Kozlov, Andrey
    Tolkunova, Polina
    Andreeva, Tatiana
    Morozova, Elena
    Punanov, Yury
    Zubarovskaya, Ludmila
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2019, 54 : 560 - 560
  • [44] Early versus late administration of pegfilgrastim after high-dose chemotherapy and autologous hematopoietic stem cell transplantation
    Kahl, C.
    Sayer, H. G.
    Hinke, A.
    Freund, M.
    Casper, J.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (03) : 513 - 517
  • [45] High-dose chemotherapy (HDCT) followed by autologous hematopoietic stem cell transplantation (HSCT) for patients with rhabdomyosarcomas (RMS)
    Peinemann, F.
    Hildebrandt, M.
    Kulig, M.
    Herrmann-Frank, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [46] High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 years
    Mehta, J.
    Singhal, S.
    BONE MARROW TRANSPLANTATION, 2007, 40 (12) : 1101 - 1114
  • [47] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA
    VOSE, JM
    ANDERSON, JR
    KESSINGER, A
    BIERMAN, PJ
    COCCIA, P
    REED, EC
    GORDON, B
    ARMITAGE, JO
    JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) : 1846 - 1851
  • [48] High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma
    Sauerbrey, A
    Bielack, S
    Kempf-Bielack, B
    Zoubek, A
    Paulussen, M
    Zintl, F
    BONE MARROW TRANSPLANTATION, 2001, 27 (09) : 933 - 937
  • [49] High-dose chemotherapy and autologous hematopoietic stem cell transplantation for 62 patients with poor prognosis breast cancer
    Fleury, J
    Béal, D
    Bay, JO
    Choufi, B
    Suzanne, F
    Dauplat, J
    Condat, P
    Bons, JM
    Curé, H
    Plagne, R
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S297 - S297
  • [50] Early versus late administration of pegfilgrastim after high-dose chemotherapy and autologous hematopoietic stem cell transplantation
    C. Kahl
    H. G. Sayer
    A. Hinke
    M. Freund
    J. Casper
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 513 - 517
12345